Omeprazol Actavis (Omeprazole)

Omeprazole targets the H+/K+ ATPase enzyme, also known as the gastric proton pump, on parietal cells. By irreversibly inhibiting this pump, it blocks the final step of acid secretion, leading to a sustained increase in gastric pH and reduced acidity.

The appropriate dose of Omeprazol Actavis is determined by the prescribing healthcare professional based on the specific indication, patient age, renal and hepatic function, and treatment duration. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for omeprazole in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Omeprazole belongs to the proton pump inhibitor class, offering more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with newer PPIs, it has a well‑established efficacy and safety profile, making it a common first‑line choice for acid‑related disorders.

Store Omeprazol Actavis at ambient temperature, preferably below 25 °C. Keep the product in its original container, protect it from moisture and direct sunlight, and ensure the packaging remains tightly closed until use.

Omeprazol Actavis is taken orally, usually as a whole tablet swallowed with water. It is generally recommended to take the dose before a meal, most commonly before breakfast, unless the prescriber advises otherwise.

Serious risks include severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated diarrhea, low magnesium levels that can cause muscle cramps or cardiac arrhythmias, and an increased risk of bone fractures with long‑term use. Patients should seek immediate medical attention if any of these occur.

Individuals with known hypersensitivity to omeprazole or any component of the formulation should avoid its use. Caution is also advised for patients with severe liver disease, those taking medications that require gastric acidity for absorption, and patients with a history of osteoporosis when long‑term therapy is considered.